Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ngm Biopharmaceuticals Inc (NGM)  
$1.54 0.00 (0.00%) as of 4:30 Thu 4/4


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 69,020,000
Market Cap: 106.29(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6003 - $3.73
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   NGM Biopharmaceuticals is a biopharmaceutical company. Co. has five product candidates in the clinic, three wholly-owned by Co. (NGM707, NGM120 and aldafermin), one being progressed by its collaborator, Merck Sharp & Dohme Corp., or Merck (MK-3655) and one optionable by Merck (NGM621). Co.'s oncology product candidates include NGM707, NGM831, NGM438 and NGM120 and their related compounds. NGM621 was engineered to bind to, and be a long-acting inhibitor of, complement C3 with the treatment goal of reducing disease progression in patients with geographic atrophy, secondary to age-related macular degeneration. MK-3655 isin Phase 2b development for the treatment of nonalcoholic steatohepatitis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 94,704 7,821,322
Total Buy Value $0 $0 $64,854 $71,005,279
Total People Bought 0 0 4 5
Total Buy Transactions 0 0 10 106
Total Shares Sold 0 0 0 85,082
Total Sell Value $0 $0 $0 $438,308
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 499
  Page 14 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Column Group Ii Gp, Lp General Partner   –       –       •   2019-11-04 4 B $11.99 $100,824 D/D 8,409 253,907 2.45     -
   Goeddel David V Director   –       •       •   2019-11-04 4 B $11.99 $100,824 I/I 8,409 16,610,814 2.25     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2019-11-04 4 S $12.26 $134,694 D/D (10,986) 996,693     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2019-11-04 4 OE $1.44 $15,820 D/D 10,986 1,007,679     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2019-11-01 4 OE $0.52 $53,730 D/D 83,153 996,693     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2019-11-01 4 S $13.29 $151,524 D/D (11,403) 924,943     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2019-10-31 4 S $12.99 $368,565 D/D (28,376) 924,943     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2019-10-31 4 OE $1.44 $40,861 D/D 28,376 953,319     -
   Column Group Iii Gp, Lp General Partner   –       –       •   2019-10-23 4 B $11.86 $24,752 D/D 2,087 245,498 2.37     -
   Goeddel David V Director   –       •       •   2019-10-23 4 B $11.86 $24,752 I/I 2,087 16,602,405 2.17     -
   Column Group Ii Gp, Lp General Partner   –       –       •   2019-10-23 4 B $11.86 $24,752 D/D 2,087 245,498 2.37     -
   Svennilson Peter Director   –       •       •   2019-10-23 4 B $11.86 $24,752 I/I 2,087 16,412,405 2.17     -
   Column Group Iii Gp, Lp General Partner   –       –       •   2019-10-22 4 B $12.00 $27,600 D/D 2,300 243,411 2.37     -
   Goeddel David V Director   –       •       •   2019-10-22 4 B $12.00 $27,600 I/I 2,300 16,600,318 2.25     -
   Column Group Ii Gp, Lp General Partner   –       –       •   2019-10-22 4 B $12.00 $27,600 D/D 2,300 243,411 2.37     -
   Svennilson Peter Director   –       •       •   2019-10-22 4 B $12.00 $27,600 I/I 2,300 16,410,318 2.25     -
   Svennilson Peter Director   –       •       •   2019-10-21 4 B $11.94 $518,196 I/I 43,400 16,408,018 2.25     -
   Column Group Iii Gp, Lp General Partner   –       –       •   2019-10-21 4 B $11.94 $518,196 D/D 43,400 241,111 2.45     -
   Column Group Ii Gp, Lp General Partner   –       –       •   2019-10-21 4 B $11.94 $518,196 D/D 43,400 241,111 2.45     -
   Goeddel David V Director   –       •       •   2019-10-21 4 B $11.94 $518,196 I/I 43,400 16,598,018 2.25     -
   Svennilson Peter Director   –       •       •   2019-10-18 4 B $11.29 $392,000 I/I 34,721 16,364,618 2.25     -
   Column Group Iii Gp, Lp General Partner   –       –       •   2019-10-18 4 B $11.29 $392,000 D/D 34,721 197,711 2.45     -
   Column Group Ii Gp, Lp General Partner   –       –       •   2019-10-18 4 B $11.29 $392,000 D/D 34,721 197,711 2.45     -
   Goeddel David V Director   –       •       •   2019-10-18 4 B $11.29 $392,000 I/I 34,721 16,554,618 2.25     -
   Svennilson Peter Director   –       •       •   2019-10-17 4 B $10.62 $72,407 I/I 6,818 16,329,897 2.25     -
  499 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 14 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us